MedPath

The genetic screening to the hereditariness breast cancer high risk group

Phase 3
Conditions
The hereditariness breast cancer high risk group
Registration Number
JPRN-UMIN000013763
Lead Sponsor
Department of Breast Disease Center, Asahikawa Medical University
Brief Summary

It does a genetic screening to the gene breast cancer high risk case. It does the positive case an active treatment or a thorough follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The hereditariness breast cancer low risk group

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The diagnosis of the BRCA gene positive case
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath